Publications by authors named "Elly Marcq"

Claim this Profile
C
Co-targeting of VEGFR2 and PD-L1 promotes survival and vasculature normalization in pleural mesothelioma.
Sophie Rovers, Jonas Van Audenaerde, Ruben Verloy, Jorrit De Waele, Louize Brants, Elly Marcq

Oncoimmunology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Minimally Invasive Transthoracic Injection Technique for Reproducible Intrapleural Delivery in Mice.
Sophie Rovers, Pooyeh Farahmand, Dana Liu, Louize Brants, Christophe Hermans, Elly Marcq

Methods Protoc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-metabolite chemotherapy increases LAG-3 expressing tumor-infiltrating lymphocytes which can be targeted by combination immune checkpoint blockade.
Nicola Principe, Amber-Lee Phung, Kofi L P Stevens, Omar Elaskalani, Ben Wylie, Elly Marcq

J Immunother Cancer· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The MexTAg collaborative cross: host genetics affects asbestos related disease latency, but has little influence once tumours develop.
Scott A Fisher, Kimberley Patrick, Tracy Hoang, Elly Marcq, Kiarash Behrouzfar

Front Toxicol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen, Ho Wa Lau, Christophe Hermans, Elly Marcq

J Hematol Oncol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-1, PD-L1, IDO, CD70 and microsatellite instability as potential targets to prevent immune evasion in sarcomas.
Vasiliki Siozopoulou, Evelien Smits, Karen Zwaenepoel, Jimmy Liu, Abraham Pouliakis, Elly Marcq

Immunotherapy· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determining the clinical utility of a breath test for screening an asbestos-exposed population for pleural mesothelioma: baseline results.
Kathleen Zwijsen, Eline Schillebeeckx, Eline Janssens, Joris Van Cleemput, Tom Richart, Elly Marcq

J Breath Res· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.
Laurie Freire Boullosa, Jinthe Van Loenhout, Tal Flieswasser, Christophe Hermans, Céline Merlin, Elly Marcq

Antioxidants (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with Cancer.
Yana Debie, Jonas R M Van Audenaerde, Timon Vandamme, Lieselot Croes, Laure-Anne Teuwen, Elly Marcq

Clin Cancer Res· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of the Solvent and In Vivo Administration Route of Auranofin in a Syngeneic Non-Small Cell Lung Cancer and Glioblastoma Mouse Model.
Laurie Freire Boullosa, Jinthe Van Loenhout, Christophe Hermans, Ho Wa Lau, Céline Merlin, Elly Marcq

Pharmaceutics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of local non-thermal plasma therapy on the cancer-immunity cycle in a melanoma mouse model.
Abraham Lin, Joey De Backer, Delphine Quatannens, Bart Cuypers, Hanne Verswyvel, Elly Marcq

Bioeng Transl Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Fusions in a Sarcomas Series: Pathology, Molecular and Clinical Aspects.
Vasiliki Siozopoulou, Elly Marcq, Koen De Winne, Koen Norga, Gertjan Schmitz

Pathol Oncol Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
External Validation of a Breath-Based Prediction Model for Malignant Pleural Mesothelioma.
Eline Janssens, Eline Schillebeeckx, Kathleen Zwijsen, Jo Raskin, Joris Van Cleemput, Elly Marcq

Cancers (Basel)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Headspace Volatile Organic Compound Profiling of Pleural Mesothelioma and Lung Cancer Cell Lines as Translational Bridge for Breath Research.
Eline Janssens, Zoë Mol, Lore Vandermeersch, Sabrina Lagniau, Karim Y Vermaelen, Elly Marcq

Front Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent Advances of Immune Checkpoint Inhibition and Potential for (Combined) TIGIT Blockade as a New Strategy for Malignant Pleural Mesothelioma.
Sophie Rovers, Annelies Janssens, Jo Raskin, Patrick Pauwels, Jan P van Meerbeeck, Elly Marcq

Biomedicines· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Fusions in Sarcomas: Diagnostic Challenges and Clinical Aspects.
Vasiliki Siozopoulou, Evelien Smits, Koen De Winne, Elly Marcq, Patrick Pauwels

Diagnostics (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Search for an Interesting Partner to Combine with PD-L1 Blockade in Mesothelioma: Focus on TIM-3 and LAG-3.
Elly Marcq, Jonas R M Van Audenaerde, Jorrit De Waele, Céline Merlin, Patrick Pauwels

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?
Vasiliki Siozopoulou, Andreas Domen, Karen Zwaenepoel, Annelies Van Beeck, Evelien Smits, Elly Marcq

Cancers (Basel)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Voluntary exercise in mesothelioma: effects on tumour growth and treatment response in a murine model.
Scott A Fisher, Carolyn J Peddle-McIntyre, Kimberley Burton, Robert U Newton, Elly Marcq

BMC Res Notes· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel combination immunotherapy for pancreatic cancer: potent anti-tumor effects with CD40 agonist and interleukin-15 treatment.
Jonas Rm Van Audenaerde, Elly Marcq, Bianca von Scheidt, Ashleigh S Davey, Amanda J Oliver

Clin Transl Immunology· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desmoid tumors display a strong immune infiltration at the tumor margins and no PD-L1-driven immune suppression.
Vasiliki Siozopoulou, Elly Marcq, Julie Jacobs, Karen Zwaenepoel, Christophe Hermans

Cancer Immunol Immunother· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cold Atmospheric Plasma-Treated PBS Eliminates Immunosuppressive Pancreatic Stellate Cells and Induces Immunogenic Cell Death of Pancreatic Cancer Cells.
Jinthe Van Loenhout, Tal Flieswasser, Laurie Freire Boullosa, Jorrit De Waele, Jonas Van Audenaerde, Elly Marcq

Cancers (Basel)· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building a Bridge between Chemotherapy and Immunotherapy in Malignant Pleural Mesothelioma: Investigating the Effect of Chemotherapy on Immune Checkpoint Expression.
Elly Marcq, Jonas Rm Van Audenaerde, Jorrit De Waele, Julie Jacobs, Jinthe Van Loenhout

Int J Mol Sci· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cells and Programmed Death-1 Blockade: A Joint Venture to Combat Cancer.
Maarten Versteven, Johan M J Van den Bergh, Elly Marcq, Evelien L J Smits, Viggo F I Van Tendeloo

Front Immunol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poly(I:C) primes primary human glioblastoma cells for an immune response invigorated by PD-L1 blockade.
Jorrit De Waele, Elly Marcq, Jonas Rm Van Audenaerde, Jinthe Van Loenhout, Christophe Deben

Oncoimmunology· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis